Have a personal or library account? Click to login
Clinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome Patients Requiring Invasive Mechanical Ventilation in a Lower Middle-Income Country Cover

Clinical Characteristics and Outcomes of COVID-19 Acute Respiratory Distress Syndrome Patients Requiring Invasive Mechanical Ventilation in a Lower Middle-Income Country

Open Access
|Feb 2022

Figures & Tables

Fig. 1

Comparison of the Area under the ROC curve between SOFA and APACHE II scoring models
Comparison of the Area under the ROC curve between SOFA and APACHE II scoring models

Laboratory parameters among survivors and non-survivors

Survivors (n=30)Non-Survivors (n=41)All patients (n=71)p-value
Hemoglobin at 24 hours ( g/dl) N=7113.05(11.5-13.5)11.9(9.85-14)12.4(10.6-13.7)0.34
Hemoglobin at 48 hours( g/dl) N=7012.05(10.7-12.9)11.05(9.45-13.15)11.75(9.97-12.97)0.112
TLC at 24 hours (x10^9/L)11.15(8.0-15.1)14.3(9.3-18.2)12.9(8.9-16.5)0.046
TLC at 48 hours (x10^9/L)11.15(8.5-14.9)13.95(9.3-20.0)12.6(12.6-16.07)0.133
Platelets count at 24 hours(x10^9/L)3310(237.25-363)224(157.5-335.5)269(198-353)0.063
Platelets count at 48 hours(x10^9/L)334.5(277.5-406.7))212.5(132.75-317.5)269.5(171.25-356.25)<0.001
Blood Urea Nitrogen(mg/dl)25(15.75-43)27(22.5-51.5)26(19-43)0.159
Blood Urea Nitrogen at 48 hours( mg/dl)26(21-49.25)37.5(28.25-58.25)35.5(22.75-54.25)0.057
Creatinine at 24 hours ( mg/dl)1.25(0.9-1.65)1.4(1.1-2.05)1.4(1-1.9)0.111
Creatinine at 48 hours(mg/dl)1(0.7-1.35)1.85(0.9-25)1.3(0.8-2.35)0.007
Sodium 24 hours (mmol/L)138.5(131.75-141)139(133-143)139(133-142)0.307
Sodium 48 hours(mmol/l)141(136.75-144)143(139.25-147.75)142.5(138-147)0.032
Bicarbonate 24 hours (mmol/L)22.3(19.3-24.8)20.7(17.5-23.45)21.9(18-24)0.102
Bicarbonate at 48 hours(mmol/L)22.8(21.2-26.8)20.65(18.75-22.5)21.55(19.9-24.5)0.002
C-Reactive Protein 24 hours (n=70) (mg/L)160(69-236)165(58-203.5)161.5(63-214.5)0.948
C-Reactive Protein at 48 hours (n=63) (mg/L)123(48.5-196)192.5(85.5-278)165(61-244)0.054
C-Reactive Protein Max (n=60) (mg/L)201(169-292)235(162-317.5)230(169.25-301)0.6
Ferritin at 24 hours (n=68) (ng/ml)879.5(420.75- 2518.5)1519(669.75-3183.5)1278.5(548.75-2566)0.159
Ferritin at 48 hours (n=53) (ng/ml)674(304-1883.5)2075(896.5-3000.5)1287(599.5-2752.75)0.008
Ferritin Max (n=61) (ng/ml)1169.5(648-4424)2282(1193.5-6727)1923(758.5-5415)0.088
D-Dimer at 24 hours (n=69) (mg/ml)1.8(1.05-4)3.65(2.1-13.72)3.3(1.25-9.5)0.038
D-Dimer at 48 hours (n=60) (mg/L )3.2(1.7-11.6)8.1(2.35-15.4)5.3(1.95-15.3)0.045
D-Dimer Max(n=61) (mg/L )5.3(2.5-16.8)18.3(6.5-30)14.5(4.6-30)0.009
Procalcitonin (n=68) (ng/ml)0.53(0.209-1.45)0.80(0.17-3.58)0.603(0.202-2.102)0.411
Procalcitonin at 48 hours (n=54) (ng/ml)0.51(0.25-2.99)2.85(0.48-9.72)1.33(0.431-7.47)0.077
LDH 24 hours (n=67) (I.U/L)650(535-774.5)667.5(569.75-867)652(569-831)0.40
LDH48(n=58) (I.U/L)575(430-696.75)670(579.25-823)618(498-743.5)0.004
pH at admission7.4(7.35-7.43)7.37 (7.25-7.43)7.39(7.32-7.43)0.21
pH 48 hours7.41(7.36-7.45)7.34 (7.27-7.41)7.39(7.315-7.43)0.001

Complications observed in patients during the hospital stay

ComplicationsFrequencyPercentage(%)
Septic Shock4462.0
Multi-organ Dysfunction3143.7
Myocardial injury3042.3
Thrombotic complications22.8
Acute kidney Injury5780.3
Renal replacement therapy1622.5
CRRT 2.8
Both CRRT/ Hemodialysis 8.5
Intermittent Hemodialysis 11.3
Hospital-acquired Pneumonia/VAP.3853.5
Acinetobacter14
Stenotrophomonas
Pseudomonas
Klebsiella
E.coli
Fungal infections2839.4
Bacteremia1318.3
Catheter-associated urinary tract infection811.3
Pneumothorax1115.5
Subcutaneous emphysema912.7
Critical illness myopathy57.2
Bed scores22.9
GI Bleed1724.6
Re-intubation45.8
Arrhythmias(new-onset)2028.1
CPR with ROSC1216.9
Diabetic ketoacidosis68.45

Multi-variate regression analysis of predictors of mortality

Variablep-valueOdds ratio (95% Confidence interval)
SOFA score Admission0.261.19(0.8-1.64)
APACHE-II score Admission0.0121.18(1.03-1.34)
PF (PA02/Fi02) ratio Admission0.200.99(0.98-1.003)
Dimer>1.5 mg/L0.0375.15(1.108-23.96)
Acute kidney injury0.750.76(0.13-4.26)
PEEP at admission (cmH20)0.261.17(0.88-1.57)

Univariate analysis of predictors of mortality

Variablep-value Odds ratio (95% Confidence interval)
Age0.52 1.01 (0.97-1.04)
Age>600.65 1.24 (0.48-3.21)
PEEP at 48 hours0.009 1.3 (1.06-1.6)
PEEP at 24 hours0.32 1.09 (0.91-1.32)
PF ratio admission0.032 0.99 (0.98-0.99)
PF ratio at 48 hours0.56 0.99 (0.99-1.003)
APACHE-II at 24 hours0.000 1.19 (1.08-1.31)
APACHE-II 48 hours0.000 1.17 (1.07-1.27)
SOFA score at 24 hours0.000 1.48 (1.19-1.85)
SOFA score at 48 hours0.000 1.47 (1.2-1.8)
Hypertension0.81 1.11 (0.434-2.87)
Acute kidney injury0.019 4.62 (1.28-16.64)
Myocardial injury0.416 1.49(0.56-3.90)
TLC at 24 hours (x10^9/L0.079 1.06 (0.99-1.14)
Platelets count at 48 hours(x10^9/L)0.001 0.99 (0.98-099)
Dimer>1.5 mg/L0.031 3.1 (1.11-8.71)
D-Dimer Maximum0.017 1.06 (1.01-1.12)
D-Dimer at 24 hours (n=69) (mg/ml)0.067 1.05 (0.996-1.12)
D-Dimer at 48 hours (n=60) (mg/L )0.089 1.05 (0.99-1.12)
C-Reactive Protein 24 hours (n=70)(mg/L)0.923 1 (0.996-1.005)
C-Reactive Protein >180 mg/L0.80 1.12 (0.43-2.9)
Procalcitonin >1 ng/ml0.236 1.82 (0.67-4.93)
LDH 24 hours (n=67) (I.U/L)0.212 1.001 (1.00-1.002)
LDH 48 hours (I.U/L)0.017 1.005(1.001-1.008)

Demographic and clinical features of the study population

Variables Median (Interquartile ranges)Survivors (n=30)Non-Survivors (n=41)All patients (n=71)P-value
Age (years)55(47.5-64)59(46-65)56(48-64)0.35
Age (years) 0.86
<4041.7%(5)58.3%(7)16.9%(12)
41-5055.6%(5)44.4%(4)12.7%(9)
51-5941.2%(7)58.8%(10)23.9%(17)
>6039.4%(13)60.6%(20)46.5%(33)
Diabetes Mellitus38.5%(15)61.5%(24)54.9%(39)0.47
Hypertension41%(16)59%(23)54.9%(39)0.81
Ischemic heart disease41.7%(10)58.3%(14)33.8%(24)0.94
Chronic kidney disease33.3%(3)66.7%(6)12.7%(9)0.72
Proning43.9%(18)56.1%(23)57.7%(41)0.74
Vasopressors requirement37.5%(15)62.5%(25)56.3%(40)0.35
BMI (kg/m2)29.5 (24.04-28.53)25.95 (24.04-28.5)25.95 (24.22-27.68)0.7
ICU Admission SOFA score5(4-7)12(9-14)7(5-9)<0.001
48 hours SOFA score4(2-6)10(9-12)6(4-10)<0.001
ICU Admission APACHE II score8(7-10)21(14-28)15(11-24)<0.001
APACHE II 48 score hours9 (6- 11)20 (12-25)13(9-23)<0.001
PEEP ICU Admission8(8-10)8(6-10)10(8-10)0.217
PEEP 48 hours10(8-11)10(8-12)10(7.75-12)0.007
Tidal volume (ml/kg) at ICU admission6(5.62-6.43)6.42(5.62-6.84)6.17(5.62-6.57)0.674
Tidal volume at 48 hours6.35(5.9-6.86)6.13(5.62-6.85)6.27(5.7-6.85)0.548
PF ratio ICU admission (PA02/Fi02)118(81.09-219.31)107.37(65.75-141.25)112.5(76.75-160)0.041
PF ratio 48 hours(PA02/Fi02)164.7(115.03-221.41)141.41(108.03-192.75)154.55(108.75-199.25)0.208
Duration of symptom onset to ER7(4-10)7(5-10)7(4-10)0.313
presentation
Symptom onset to ICU admission9(5.7-11.25)9(7-12)9(7-12)0.472
Length of ICU stay6(4-9)8(4-11.5)8(4-10)0.177
Length of ICU stay with IMV4.5(3-7)8(4-11)6(3-10)0.008
The total length of stay17(10.75-21.25)9(7.5-15)11(8-20)0.001
Acute kidney injury66.6%(20)90.2%(37)80.3%(57)0.014

Area under ROC curve and cut-off values of APACHE II and SOFA score for prediction of mortality

Scoring variableArea under ROC curve (95% confidence interval)Standard errorp-valueCut-of valueSensitivitySpecificity
Admission APACHE II score0.803(0.697-0.908).0540.00001613.50.7750.70
48 hour APACHE II score0.795(0.687-0.903).0550.00002712.50.750.80
Admission SOFA score0.763(0.649-0.876).0580.0001816.50.7750.67
48 hour SOFA score0.805(0.699-0.910).0540.0000145.50.800.70
DOI: https://doi.org/10.2478/jccm-2021-0044 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 23 - 32
Submitted on: Jun 14, 2021
|
Accepted on: Dec 9, 2021
|
Published on: Feb 9, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Taymmia Ejaz, Fazal Rehman, Arslan Ahmed, Safia Akhlaq, Sheema Saadia, Adil Aziz, Erfan Hussain, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.